Here’s Why Prosfora’s Amit Ranjan Believes Indian Drugmakers Fall Short Of U.S. FDA Standards
An employee checks a vaccine vial moving along a vaccine vial monitor labeling machine at the Serum Institute of India’s pharmaceutical plant in Pune, Maharashtra, India. (Photographer: Sanjit Das/Bloomberg)

Here’s Why Prosfora’s Amit Ranjan Believes Indian Drugmakers Fall Short Of U.S. FDA Standards

Indian drugmakers specialising in sterile products have a long way to go before meeting specifications of the U.S. Food and Drug Administration.That’s according to Amit Ranjan, managing director of...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.